With their high recombinant antibody production services, recombinant antibodies have revolutionized biomedical research. However, the process of producing antibodies by immunizing animals and isolating hybridomas has significant drawbacks, such as variable results, batch-to-batch variation, and the need to perform complex screening processes to isolate monoclonal antibody candidates. With recombinant antibody production services, researchers can overcome these challenges to achieve consistent, high-quality antibodies that are useful for various applications, including therapeutics.
Choosing the Right Multiplex IHC Provider for High-Precision Biomarker Analysis
The process of recombinant antibody production involves acquiring the variable regions (VH and VL) of an existing hybridoma antibody or antibody library using RT-PCR and sequencing, constructing expression vectors containing constant regions, and transfecting them into mammalian cells, such as CHO and HEK293. The antibodies are selected for binding to the antigen of interest, and unspecific antibodies are washed away so that only those that bind successfully can be selected for further development. This method of antibody production is a much faster and more effective way to produce antibodies than conventional methods.
Once the antibodies are selected for further development, they are purified to remove process-related impurities. During this step, Protein A affinity chromatography efficiently captures the antibodies and other host cell proteins to provide a highly pure product with a low endotoxin level. Size exclusion chromatography is used to further refine the product, and ion exchange chromatography removes a variety of other contaminants from the final antibody product.
The benefits of recombinant antibody production include easy engineering and optimization, high specificity and stability, humanization options, and the ability to produce custom formats. However, reliance on an external partner can potentially lead to loss of control over proprietary data and timelines. To prevent these issues, specialized antibody expression partners offer transparent services, with fully traceable Matrix 2D barcoded sample tubes, strict confidentiality and data security standards, and an on-call team for consistent project communication.
…